Literature DB >> 23824897

Mouse model of invasive fungal infection.

Donna M MacCallum1.   

Abstract

The mouse intravenous (IV) challenge model of Candida albicans invasive fungal infection has been widely used to study the importance of the innate immune system in these infections. This chapter describes this well-characterized model, where fungal cells are administered directly into the mouse bloodstream to initiate a systemic infection. The preparation of tissue samples from infected mice to allow evaluation of disease progression and host responses is also described.

Entities:  

Mesh:

Year:  2013        PMID: 23824897     DOI: 10.1007/978-1-62703-481-4_17

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  6 in total

1.  Acetylcholine Protects against Candida albicans Infection by Inhibiting Biofilm Formation and Promoting Hemocyte Function in a Galleria mellonella Infection Model.

Authors:  Ranjith Rajendran; Elisa Borghi; Monica Falleni; Federica Perdoni; Delfina Tosi; David F Lappin; Lindsay O'Donnell; Darren Greetham; Gordon Ramage; Christopher Nile
Journal:  Eukaryot Cell       Date:  2015-06-19

Review 2.  Overview of vertebrate animal models of fungal infection.

Authors:  Tobias M Hohl
Journal:  J Immunol Methods       Date:  2014-04-04       Impact factor: 2.303

3.  Rewiring monocyte glucose metabolism via C-type lectin signaling protects against disseminated candidiasis.

Authors:  Jorge Domínguez-Andrés; Rob J W Arts; Rob Ter Horst; Mark S Gresnigt; Sanne P Smeekens; Jacqueline M Ratter; Ekta Lachmandas; Lily Boutens; Frank L van de Veerdonk; Leo A B Joosten; Richard A Notebaart; Carlos Ardavín; Mihai G Netea
Journal:  PLoS Pathog       Date:  2017-09-18       Impact factor: 6.823

Review 4.  Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.

Authors:  Patrick Van Dijck; Jelmer Sjollema; Bruno P Cammue; Katrien Lagrou; Judith Berman; Christophe d'Enfert; David R Andes; Maiken C Arendrup; Axel A Brakhage; Richard Calderone; Emilia Cantón; Tom Coenye; Paul Cos; Leah E Cowen; Mira Edgerton; Ana Espinel-Ingroff; Scott G Filler; Mahmoud Ghannoum; Neil A R Gow; Hubertus Haas; Mary Ann Jabra-Rizk; Elizabeth M Johnson; Shawn R Lockhart; Jose L Lopez-Ribot; Johan Maertens; Carol A Munro; Jeniel E Nett; Clarissa J Nobile; Michael A Pfaller; Gordon Ramage; Dominique Sanglard; Maurizio Sanguinetti; Isabel Spriet; Paul E Verweij; Adilia Warris; Joost Wauters; Michael R Yeaman; Sebastian A J Zaat; Karin Thevissen
Journal:  Microb Cell       Date:  2018-06-14

5.  Intravenous delivery of a liposomal formulation of voriconazole improves drug pharmacokinetics, tissue distribution, and enhances antifungal activity.

Authors:  Danillo F M C Veloso; Naiara I G M Benedetti; Renato I Ávila; Thiago S A Bastos; Thaísa C Silva; Maria R R Silva; Aline C Batista; Marize C Valadares; Eliana M Lima
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

6.  A novel renal epithelial cell in vitro assay to assess Candida albicans virulence.

Authors:  Edina K Szabo; Donna M Maccallum
Journal:  Virulence       Date:  2013-11-13       Impact factor: 5.882

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.